Amarin Corp Plc (AMRN)

[ziploc_1]

Amarin needs to PR Amarin's patented gelatin capsules used in Vascepa... but NOT used in gV....and Amarin needs to mention in their adds that this is another reason why branded Vascepa is superior to gV

...These capsular patents are exclusively owned by Amarin....Docs and the public may be unaware that these patented capsules are another way that Vascepa is superior to gV.

QUOTE..."Amarin has patent protection for Vascepa capsules out to 2030, including protection related to the expanded Reduce-It trial label....
Two U.S. formulation patents and 22 U.S. Vascepa Patents expire between 1/27/20 and 4/29/30, with 21 of 22 expiring in 2030.
Two of the 22 "method of use" Vascepa patents are relevant to the expanded label from the Reduce-It trial."